Abstract
Daratumumab in Combination with Carfilzomib and Dexamethasone in Patients (pts) with Relapsed Multiple Myeloma (MMY1001): An Open-Label, Phase 1b Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have